E207-0026 Screening compound: N~4~-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4-piperidinecarboxamide

E207-0026 Screening compound: N~4~-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4-piperidinecarboxamide
E207-0026 Screening compound: N~4~-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4-piperidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E207-0026
N~4~-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4-piperidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E207-0026

Molecular Formula

C23H24N4O5 (C23 H24 N4 O5)

Compound Name

N~4~-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4-piperidinecarboxamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-1-[3-(4-methoxyphenyl)-124-oxadiazol-5-yl]piperidine-4-carboxamide

SMILES

COc(cc1)ccc1-c1noc(N(CC2)CCC2C(Nc(cc2)cc3c2OCCO3)=O)n1

InChI

InChI=1S/C23H24N4O5/c1-29-18-5-2-15(3-6-18)21-25-23(32-26-21)27-10-8-16(9-11-27)22(28)24-17-4-7-19-20(14-17)31-13-12-30-19/h2-7,14,16H,8-13H2,1H3,(H,24,28)

InChI Key

WVGLUBZIGVDZAS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14845931

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.761

Distribution Coefficient, logD

2.761

Water Solubility, LogSw

-3.43

Polar Surface Area

81.898

Acid Dissociation Constant (pKa)

10.77

Base Dissociation Constant (pKb)

3.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.78

E207-0026 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E207-0026 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E207-0026?
Check Price and Availability of E207-0026, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E207-0026 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E207-0026
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E207-0026
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E207-0026 available by request